Gastric atrophy and intestinal metaplasia before and after helicobacter pylori eradication: A Meta-analysis

Digestion

Volumn 83, Issue 4, 2011, Pages 253-260

  Wang, Jin ^a,b   Xu, Lijuan ^a   Shi, Ruihua ^a   Huang, Xiayue ^a   Li, Simon Wing Heng ^c   Huang, Zuhu ^a   Zhang, Guoxin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b Municipal Hospital of Dongtai   (China)

^c PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Eradication; Gastric atrophy; Helicobacter pylori; Intestinal metaplasia; Meta analysis

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ARTICLE; DISEASE ASSOCIATION; ERADICATION THERAPY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MEDICAL LITERATURE; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; STOMACH ANTRUM; STOMACH ATROPHY; STOMACH DISEASE; SYSTEMATIC REVIEW;

GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; METAPLASIA; PYLORIC ANTRUM; STOMACH; TREATMENT OUTCOME;

EID: 79251592276     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000280318     Document Type: Article

References (39)

1. Parsonnet J: Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 1993; 22: 89-104. (Pubitemid 23123007)
2. Yoshida S, Saito D: Gastric premalignancy and cancer screening in high risk patients. Am J Gastroenterol 1996, 91: 839-843. (Pubitemid 26143516)
3. Ferlay J, Bray F, Pisani P, Parkin DM: Globocan 2000: Cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC Cancer Base No.5. Lyon, IARC Press, 2001.
4. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
5. Buckley M, O'Morain C: Prevalence of in non-ulcer dyspepsia. Aliment Pharmacol Ther 1995; 9(suppl):53-58.
6. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancer 1984;1:1311-1315.
7. Marshall BJ, Windsor HM: The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology epidemiology, screening clinical presentation treatment, and prevention. Med Clin North Am 2005; 89: 313-344. (Pubitemid 40126820)
8. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65-69.
9. Parsonnet J, Hansen S, Rodriguez L, Gelb B, Warnke RA, Jellum E, Vogelman JH, Friedman GD: Helicobacter pylori infection and gastric lymphoma. N Engl J med 1994; 330: 1267-1271. (Pubitemid 24129959)
10. Infection with Helicobactor pylori : IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, vol 61. Schistosomes, Liver Flukes, and Helicobactor pylori . Lyon, International Agency for Research on Cancer, 1994, pp 177-241.
11. Ekstrom AM, Held M, Hansson LE, et al: Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791. (Pubitemid 32959388)
12. Brenner H, Arndt V, Stegmaier C, et al: Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004; 159: 252-258. (Pubitemid 38141654)
13. Huang JQ, Sridhar S, Chen Y, et al: Metaanalysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterol 1998; 114: 1169-1179. (Pubitemid 28243902)
14. Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori : a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
15. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-6740. (Pubitemid 23006271)
16. Malfertheiner P, Sipponen P, Naumann M, et al: H. pylori -Gastric Cancer Task Force: Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-theart critique. Am J Gastroenterol 2005; 100: 2100-2115.
17. Chen X, Haruma K, Kamada T, et al: Factors that affect results of the 13 C-urea breath test in Japanese patients. Helicobacter 2000; 5: 98-103. (Pubitemid 34948015)
18. Price AB: The Sydney system: histological division. J Gastroenterol Hepatol 1991; 6: 209-222.
19. Dixon MF, Genta RM, Yardley JH, et al: Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-1181. (Pubitemid 26336840)
20. Undertaking Systematic Reviews of Research on Effectiveness. CRD's Guidance for Those Carrying Out or Commissioning Reviews. CRD Report No 4. University of York, Centre for Reviews and Dissemination, 2001.
21. Iacopini F, Consolazio A, Bosco D, et al: Oxidative damage of the gastric mucosa in Helicabacter pylori positive chronic atrophic and nonatrophic gastritis, before and after eradication. Helicobacter 2003; 8: 503-512. (Pubitemid 37288098)
22. Kamada T, Haruma K, Hata J, et al: The longterm effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther 2003; 18: 245-252. (Pubitemid 36951662)
23. Lu B, Chen MT, Fan YH, Liu Y, Meng LN: Effects of Helicobacter pylor I eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study. World J Gastroenterol 2005; 11: 6518-6520. (Pubitemid 43136891)
24. Sung JJ, Lin SR, Ching JY, et al: Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14. (Pubitemid 30452573)
25. Tucci A, Poli L, Tosetti C, et al: Reversal of fundic atrophy after eradication of Helicobacter pylori . Am J Gastroenterol 1998; 93: 1425-1431. (Pubitemid 29075176)
26. Ruiz B, Garav J, Correa P, et al: Morphometric evaluation of gastric antral atrophy: Improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001; 96: 3281-3287. (Pubitemid 34016649)
27. Ito M, Haruma K, Kamada T, et al: Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 1449-1456. (Pubitemid 34953585)
28. Kamada T, Hata J, Sugiu K, et al: Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori : results from a 9-year prospective follow-up study in Japan. Aliment Pharmacol Ther 2005; 21: 1121-1126. (Pubitemid 40646538)
29. Lahner E, Bordi C, Cattaruzza MS, et al: Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection. Aliment Pharmacol Ther 2005; 22: 471-481. (Pubitemid 41248115)
30. Oda Y, Miwa J, Kaise M, et al: Five-year follow- up study on histological and endoscopic alterations in the gastric mucosa after Helicobacter pylori eradication. Dig Endosc 2004; 16: 213-218. (Pubitemid 38980974)
31. Wambura C, Nobuo A, Shirasaka D, et al: Influence of gastritis on cyclooxygenase-2 expression before and after eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2004; 16: 969-979. (Pubitemid 39411113)
32. Toyokawa T, Suwaki K, Miyake Y, et al: Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a longterm prospective cohort study. J Gastroenterol Hepatol 2010;25:434-435.
33. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. (Pubitemid 26120810)
34. Zhou L, Sung JJ, Lin S, et al: A five-year follow- up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003; 116: 11-14. (Pubitemid 36432713)
35. Leung WK, Lin SR, Ching JY, et al: Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-1249. (Pubitemid 39120105)
36. Mera R, Fontham ET, Bravo LE, et al: Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-1540. (Pubitemid 41531767)
37. You WC, Brown LM, Zhang L, et al: Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-983. (Pubitemid 44288162)
38. Rokkas T, Pistiolas D, Sechopoulos P, et al: The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis. Helicobacter 2007; 12: 32-38. (Pubitemid 350076224)
39. Moayyedi P: Meta-analysis: can we mix apples and oranges? Am J Gastroenterol 2004; 99: 2297-2301. (Pubitemid 40039355)